Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures
NCT02679560Phase 2Terminated
- Start
- Oct 2017
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine in femoral fracture, hip fracture. Started Oct 2017; status: terminated.
02
Drugs
bupivacaine
03
Conditions
femoral fracturehip fracture
Beyond the preview
Go deeper on NCT02679560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02679560.